WS #10440

17:53→18:11 UTC
From 499 msgs · 8 key-dev

AbbVie agrees to acquire Apogee Therapeutics for ~$10.9B, adding late-stage immunology and inflammation programs.

AbbVie Acquires Apogee Therapeutics

AbbVie agrees to acquire Apogee Therapeutics for ~$10.9B, adding late-stage immunology and inflammation programs.

Full world state #10440 →

U.S.-Iran Peace ProgressAI Talent Exodus from AlphabetTesla Megapod Trademark FilingYen Jumps on Katayama-Bessent Talks
← WS #10439WS #10441 →
BearishNegativeNeutralPositiveBullish|ORDER: SIZE ▾↻ RESHUFFLE▸ LATER / NOW|